Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.02% vs -17.61% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 47.14% vs -87.50% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 106.82% vs -233.33% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -100.00% vs 21.88% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Hunan Jingfeng Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.02% vs -17.61% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -5.68% vs -46.08% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 47.14% vs -87.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 87.12% vs -335.35% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 106.82% vs -233.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -91.18% vs 240.00% in Sep 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






